File Download

There are no files associated with this item.

Supplementary

Conference Paper: Antithrombotic Therapy in Patients Undergoing Joint Replacement Surgery — How Common is It?

TitleAntithrombotic Therapy in Patients Undergoing Joint Replacement Surgery — How Common is It?
Authors
Issue Date2013
PublisherHong Kong Academy of Medicine Press.
Citation
The 33rd Annual Congress of the Hong Kong Orthopaedic Association (HKOA), Hong Kong, China, 23-24 November 2013. In the Abstracts of the 33rd Annual Congress of the Hong Kong Orthopaedic Association (HKOA), 2013, p. 35, abstract no. 4.4 How to Cite?
AbstractIntroduction: It is common for patients on antithrombotic therapy to undergo joint replacement surgeries nowadays. This study aimed to document the locoregional prevalence and to explore whether there is an increasing number of these patients. Materials and Methods: Patients who underwent elective primary total knee replacement (TKR) and primary total hip replacement (THR) surgeries in 2007 and 2012 in Queen Mary Hospital were searched via the electronic clinical management system. The electronic patient records were reviewed to identify those who were on antithrombotic therapy. Data of these patients were then analysed using IBM SPSS Statistics v21.0. Statistical significance was performed using Pearson Chi-square test. Results: A total of 131 patients (mean age, 64.8 years; 61.8% with TKR and 38.2% with THR) and 324 patients (mean age, 67.9 years; 78.4% with TKR and 21.6% with THR) received total joint replacement surgeries in 2007 and 2012, respectively. The proportion of patients who were on antithrombotic therapy was significantly higher in 2012 (16%) compared with that in 2007 (8.4%) [p = 0.032]. The most common antithrombotic therapy was aspirin monotherapy (88.9%). The most common indication for antithrombotic therapy was ischaemic heart disease (44.4%). Discussion and Conclusion: There is an increasing trend of patients undergoing total joint replacement surgeries who are on antithrombotic therapy. It is increasingly important for the orthopaedic surgeon to be familiar with the perioperative management of patients on antithrombotic therapy.
DescriptionConference Theme: Defying the Aging Spine
Concurrent Free Papers 4: Hips and Knees I
Persistent Identifierhttp://hdl.handle.net/10722/204327

 

DC FieldValueLanguage
dc.contributor.authorLee, HLRen_US
dc.contributor.authorChiu, PKYen_US
dc.contributor.authorNg, FYen_US
dc.contributor.authorYan, CHen_US
dc.contributor.authorChan, PKen_US
dc.date.accessioned2014-09-19T22:41:14Z-
dc.date.available2014-09-19T22:41:14Z-
dc.date.issued2013en_US
dc.identifier.citationThe 33rd Annual Congress of the Hong Kong Orthopaedic Association (HKOA), Hong Kong, China, 23-24 November 2013. In the Abstracts of the 33rd Annual Congress of the Hong Kong Orthopaedic Association (HKOA), 2013, p. 35, abstract no. 4.4en_US
dc.identifier.urihttp://hdl.handle.net/10722/204327-
dc.descriptionConference Theme: Defying the Aging Spine-
dc.descriptionConcurrent Free Papers 4: Hips and Knees I-
dc.description.abstractIntroduction: It is common for patients on antithrombotic therapy to undergo joint replacement surgeries nowadays. This study aimed to document the locoregional prevalence and to explore whether there is an increasing number of these patients. Materials and Methods: Patients who underwent elective primary total knee replacement (TKR) and primary total hip replacement (THR) surgeries in 2007 and 2012 in Queen Mary Hospital were searched via the electronic clinical management system. The electronic patient records were reviewed to identify those who were on antithrombotic therapy. Data of these patients were then analysed using IBM SPSS Statistics v21.0. Statistical significance was performed using Pearson Chi-square test. Results: A total of 131 patients (mean age, 64.8 years; 61.8% with TKR and 38.2% with THR) and 324 patients (mean age, 67.9 years; 78.4% with TKR and 21.6% with THR) received total joint replacement surgeries in 2007 and 2012, respectively. The proportion of patients who were on antithrombotic therapy was significantly higher in 2012 (16%) compared with that in 2007 (8.4%) [p = 0.032]. The most common antithrombotic therapy was aspirin monotherapy (88.9%). The most common indication for antithrombotic therapy was ischaemic heart disease (44.4%). Discussion and Conclusion: There is an increasing trend of patients undergoing total joint replacement surgeries who are on antithrombotic therapy. It is increasingly important for the orthopaedic surgeon to be familiar with the perioperative management of patients on antithrombotic therapy.-
dc.languageengen_US
dc.publisherHong Kong Academy of Medicine Press.-
dc.relation.ispartofAnnual Congress of the Hong Kong Orthopaedic Association (HKOA)en_US
dc.rightsAnnual Congress of the Hong Kong Orthopaedic Association (HKOA). Copyright © Hong Kong Academy of Medicine Press.-
dc.titleAntithrombotic Therapy in Patients Undergoing Joint Replacement Surgery — How Common is It?en_US
dc.typeConference_Paperen_US
dc.identifier.emailLee, HLR: rhllee@hku.hken_US
dc.identifier.emailChiu, PKY: pkychiu@hkucc.hku.hken_US
dc.identifier.emailNg, FY: fyng@hkucc.hku.hken_US
dc.identifier.emailYan, CH: yanchoi@hku.hken_US
dc.identifier.emailChan, PK: cpk464@hku.hken_US
dc.identifier.authorityChiu, PKY=rp00379en_US
dc.identifier.authorityYan, CH=rp00303en_US
dc.identifier.hkuros235765en_US
dc.identifier.hkuros240319-
dc.identifier.spage35, abstract no. 4.4en_US
dc.identifier.epage35, abstract no. 4.4en_US
dc.publisher.placeHong Kong, China-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats